Depression and quality of life among patients with dermatophyte infections at a rural tertiary care hospital-A cross sectional study

The relation between psychiatry and skin diseases is bidirectional. Despite proper drug compliance and adequate treatment, there are still recurrences. This has significant impact on mental health, which may cause psychiatric comorbidity, typically anxiety and depression. We have screened for the prevalence and severity of the same, to further understand this equation. To evaluate depression and assess its severity and association with dermatophyte infections in patients at a tertiary care hospital. This cross-sectional observational study included patients with fungal infections from dermatology consultations. Basic demographics were collected, and the severity of depression and anxiety was evaluated using the Hospital Anxiety and Depression Scale (HADS) and Beck’s Depression Inventory (BDI). The Dermatological Quality of Life Index (DLQI) was used to assess quality of life. A survey of 183 dermatophytosis patients (88 male, 95 female) found the highest incidence in the third to sixth decades of life. Most had comorbid conditions, substance use history, and experienced one to six months of illness. Patients with itchy lesions had poor hygiene, contact with domestic animals, and irregular bathing. The Hospital Anxiety and Depression Scale indicated borderline anxiety and depression, with minimal to moderate depression. The Dermatological Quality of Life Index showed minimal to moderate effects, significantly impacting quality of life. This study explores the mental health impact of dermatophytosis in India, highlighting its multidimensional nature and the need for a comprehensive understanding of its psychological toll.